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Pedro M. M. Araújo1,2, Alexandre Carvalho1,2,3, Marta pingarilho4, BEST-HOPE study group*, 
Ana B. Abecasis4 & Nuno S. osório  1,2
HIV-1 subtypes associate with differences in transmission and disease progression. Thus, the existence 
of geographic hotspots of subtype diversity deepens the complexity of HIV-1/AIDS control. The already 
high subtype diversity in Portugal seems to be increasing due to infections with sub-subtype A1 virus. 
We performed phylogenetic analysis of 65 A1 sequences newly obtained from 14 Portuguese hospitals 
and 425 closely related database sequences. 80% of the A1 Portuguese isolates gathered in a main 
phylogenetic clade (MA1). Six transmission clusters were identified in MA1, encompassing isolates from 
Portugal, Spain, France, and United Kingdom. The most common transmission route identified was 
men who have sex with men. The origin of the MA1 was linked to Greece, with the first introduction to 
Portugal dating back to 1996 (95% HPD: 1993.6–1999.2). Individuals infected with MA1 virus revealed 
lower viral loads and higher CD4+ T-cell counts in comparison with those infected by subtype B. The 
expanding A1 clusters in Portugal are connected to other European countries and share a recent 
common ancestor with the Greek A1 outbreak. The recent expansion of this HIV-1 subtype might be 
related to a slower disease progression leading to a population level delay in its diagnostic.
The Human immunodeficiency virus 1 (HIV-1) pandemic is characterized by an extensive genetic diversity of 
the pathogen, a consequence of high viral replication, recombination, and mutation rates1,2. Among the four 
existing HIV-1 groups3 only the M group has a global distribution. This group is consensually divided into several 
subtypes (A-D, F-H, J, K), sub-subtypes (A1 to A4 and F1 and F2) and an increasing number of recombinant 
forms4,5. The genetic diversity among HIV-1 subtypes may cause different disease progression rates6–9, advantages 
in specific transmission routes10,11, different capacities to evade the immune response12,13 and was associated with 
specific differential therapy outcomes14–17. Moreover, HIV-1 subtypes surveillance proved to be an important tool 
to reconstruct the history of an epidemic over time18,19.
The global distribution of HIV-1 subtypes has been heterogeneous but well compartmentalized20. However, 
in recent decades the HIV-1 subtype geographic distribution pattern became more complex21–23. The number 
of non-B infections is increasing24–30 in Western and Central Europe (WCE), where subtype B has long been 
predominant. The infections by non-B subtypes in this region were commonly linked to immigrants from other 
geographic locations19,21. Nevertheless, the transmission of previously rare subtypes is increasing among native 
individuals25,31–35.
Portugal has one of the highest numbers of new HIV infections among Western European countries and an 
atypical HIV-1 subtype diversity due to the high prevalence of G subtype25,27,36. When studying new HIV-1 infec-
tions in Europe from 2002 to 2005, Abecasis et al. highlighted Portugal as the European country with more non-B 
subtype infections (60.8%)19. A recent study25 of a Portuguese cohort from the region of Minho (Northwest) 
reported the predominance of G and B subtypes followed by recombinant forms. The authors also showed the 
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existence of non-B and non-G transmission clusters, related to the increasing number of new infections by A1 
and F1 sub-subtypes25.
In the present study, we performed a multicenter characterization of the HIV-1 sub-subtype A1 infections 
in Portugal. Using a phylogenetic approach, we inferred regional and multinational transmission chains while 
estimating their geographic and temporal origins.
Results
Characterization of the phylogenetic relationship among study sequences. The phylogenetic 
representation (Fig. 1) demonstrated that 80% (52 of 65) of the A1 sub-subtype virus isolated in 14 Portuguese 
hospitals clustered together in a main A1 clade (MA1, n = 61). Most of the study sequences (96%, 50 of 52) within 
MA1 were isolated from individuals of Portuguese nationality. MA1 also included sequences obtained from pub-
lic databases isolated in Spain, France, and United Kingdom (10%, 5 of 61). MA1 was nested in the phylogeny 
with most of the sequences isolated in WCE.
The remaining sub-subtype A1 isolates sequenced in this study (13 of 65) are scattered over the tree. From 
which, five clustered with sequences isolated in African countries. Among those are four sequences isolated from 
African immigrants (Supplementary Table 1). The other eight, including three sequences isolated from Ukrainian 
nationals, were highly related to isolates from East Europe (see Supplementary Table 1).
Overall, these results suggest that there were several introductions of sub-subtype A1 viruses in Portugal, from 
at least three different geographic regions: Europe not East; Africa; and Eastern Europe. However, most of the 
sampled infections (>80%) were caused by a monophyletic introduction of a sub-subtype A1 virus.
Most recent common ancestor characterization. To better understand the most recent history of the 
sub-subtype A1 spread in Portugal the MA1 and closely related database sequences (total n = 99) were analyzed. 
This dataset is mainly composed by isolates from Western (France, Portugal, Spain, and United Kingdom) and 
Southern (Cyprus and Greece) European countries (Fig. 2). The estimate for the date of the most recent common 
ancestor (MRCA) of the MA1 is mid 1996 (95% highest posterior density (HPD): 1993.6–1999.2). The taxa out-
side the MA1 but closely related to it, sharing and older MRCA (1990.9; 95 HPD: 1986.8–1994.6), were almost 
exclusively sampled in Greece and Cyprus. Therefore, this data demonstrates the European ancestry of the MA1 
viruses expanding in Portugal.
Transmission clusters characterization. From the 61 taxa in the MA1, 46 (~75%) are part of six 
well-delimited transmission clusters (TC1 to TC6, Table 1). TC5 is the smallest with 3 sequences, followed by TC2 
with 5, TC1, TC3 and TC4 with 6. Interestingly, TC6 included 20 sequences. Eight sequences in all the clusters 
lacked demographic information. Among those with available data, two sequences were isolated from females 
Figure 1. Phylogenetic representation of the A1 sequences isolated in Portugal and closely related sequences 
from databases. Circular cladogram representation of the Maximum likelihood tree (Supplementary Fig. 1) 
with the study A1 sequences and the closely related database sequences (n = 490). Branch colours indicate the 
geographical origin of the sequences. The tip points indicate if the taxa are an A1 sequence from this study or a 
database sequence. Most of this study sequences cluster together in a well-defined area of the phylogeny (52 of 
65), here further mentioned as the main A1 cluster (MA1). The light grey background encompasses the MA1 
and closely related sequences used for further analyses (n = 99, aLRT SH-like branch support = 0.95).
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and 36 from males. The self-reported transmission route for all transmission clusters is 100% sexual, being the 
majority (59%) men who have sex with men (MSM). However, in TC5 and TC2 self-reported heterosexual trans-
mission dominated, while in TC4 only MSM is reported. These results suggest a strong association of the MA1 
transmission clusters with males and MSM route of transmission.
All the transmission clusters (TC) in this study are multicenter and TC6 is multinational. Three transmis-
sion clusters (2, 3, and 5) are composed by isolates from the cities of Braga and Porto, in the northern region of 
Portugal. The same pattern is observed for the central region of Portugal, with isolates from Aveiro, Coimbra, 
Lisbon and Setúbal in TC1 and TC4. This result suggests some level of regional compartmentalization in the 
transmission of MA1 viruses in Portugal. However, TC6, with 20 taxa, includes isolates from several Portuguese 
regions (North: Braga, Centre: Lisbon and Setúbal; South: Faro) and isolates from France, Spain, and the United 
Kingdom. This supports that the transmission history of this cluster is not restricted to Portugal.
The estimates for the time of the MRCA for each cluster were at the first two decades of the 2000s. The cluster 
depth (diagnostic date of the most recent sample minus the time of MRCA) showed that transmission of TC 1, 3, 
and 6 are expected to be ongoing for at least one decade. It is also of notice that all the transmission clusters have 
at least one taxon isolated in the years of 2016 or 2017, suggesting the emergent character of these transmission 
clusters.
Phylogeographic root and discrete rates among countries. A phylogeographic analysis was per-
formed using the country of sample collection as a discrete trait (Fig. 3, Supplementary Video). Greece had the 
highest posterior probability for the tree root (pp = 0.84). Nevertheless, most of the countries in the analysis are 
in the 95% HPD interval for the tree root. A total of 6 (ES-PT, CY-GR, GB-GR, GR-US, ES-FR, BG-GR) pairwise 
rates of diffusion between locations have a strong support value (Bayes factor >1037, Fig. 3E, Supplementary 
Table 2). Greece is the most common location among well supported rates of diffusion, being present in four. 
These rates highlight that several geographic locations, at a given point of the transmission history were not only 
receivers but also donors.
Figure 2. Evolution of the study sub-subtype A1 transmission chain through its most recent history in several 
European countries. Maximum clade credibility tree summarised from the output trees from the BEAST 
analyses (n = 99). The tip point colours represent the country where the samples were collected. The blue 
branch lines indicate that the respective HIV-1 sequence belong to a transmission cluster. The vertical black bars 
demonstrate the taxa included in each transmission cluster and the main A1 clade (MA1). The aLRT SH-like 
branch support and posterior probability (pp) of each of the transmission clusters is displayed (aLRT/pp). The 
density plot in the bottom left refers to the time of the most recent common ancestor of the MA1. The country 
of sampling of the taxa labelled as others is: USA (3); Belgium (3); Sweden (1); Australia (1); The Netherlands 
(1), and Kuwait (1).
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CD4+ T-cell levels and amino acid variant characterization. To investigate the association of MA1 
viruses with CD4+ T-cell counts or viral load a comparison with a matched control group was performed. The 
groups are composed by individuals infected with MA1 viruses (n = 50, 11 cases were excluded due to lack of clin-
ical data) and subtype B (n = 42), matching for gender, age and proportion of ambiguous sites (PAS - as a surrogate 
of time of infection38–41). The values for the CD4+ T-cell counts and viral load of the two groups are statistically 
different (p < 0.05, Mann-Whitney-Wilcoxon Test, Fig. 4A,B). To investigate if the viral genotype could contribute 
to these findings the prevalence of the existing amino acid variants was compared between the two groups. For 15 
amino acid sites in the protease and 19 in the reverse transcriptase there are marked differences (Bonferroni cor-
rection of Fisher Exact Test, p < 0.05) in the proportion of the variants when comparing MA1 vs. B (Supplementary 
Tables 3 and 4). Interestingly, some of these sites (protease: 14, 20, 35, 36, 37, 41, 57, 63, 64, 71, and 89; reverse 
transcriptase: 207) were previously reported to influence viral fitness (Supplementary Tables 3 and 4)42–46. 
We evaluated if there were associations between the amino acid variants and CD4+ T-cell counts or viral load. The 
Cluster
No of individuals
Route of transmission (n)
Sampling date Time of MRCA Cluster 
Depth Sample originTotal Male Female Unknown Mean Range Mean 95% HPD
TC1 6 4 0 2 MSM (3), Heterosexual (1), Unknown (2) 2011.7 2003–2016 2002 2000.8–2002.9 14 Multicenter
a
TC2 5 3 2 0 MSM (1), Heterosexual (4) 2014 2011–2016 2007.5 2004.9–2009.8 8.5 Multicentera
TC3 6 6 0 0 MSM (4), Heterosexual (2) 2015.2 2011–2017 2007.3 2004.2–2010.0 9.6 Multicentera
TC4 6 6 0 0 MSM (6) 2016 2016–2016 2007.9 2005.0–2010.7 8.1 Multicentera
TC5 3 3 0 0 MSM (1), Heterosexual (2) 2014.7 2012–2016 2009.3 2006.9–2011.4 6.7 Multicentera
TC6 20 14 0 6 MSM (12), Heterosexual (2), Unknown (6) 2013.5 2006–2017 2001.2 1998.8–2003.2 15–8 Multicenter
a, Multinationalb
Table 1. Characterization of the six transmission clusters identified in the main A1 cluster. aSamples from more 
than one of the 14 Portuguese hospital centers. bFrance, Portugal, Spain, and United Kingdom.
Figure 3. Phylogeographic evolution of the Main A1 clade. Geographical display of the phylogeny built using 
BEAST with the country of the sequence origin as discrete trait. (A) In the year of 1996 this transmission history 
reached Western Europe, arriving to Portugal. (B) After a decade, in 2006, viruses from this clade are expected 
to be found in several countries from different geographic regions. Some countries, like Portugal, started 
now being donors and not only receivers in this transmission history. (C) In 2017 the spread among several 
European countries is established. (D) Global representation of this transmission history; (E) Rates between 
country pairs with Bayes Factor superior to 5.
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results were not statistically significant. Of note, the amino acid sites 14, 36, 71 and 89 in the protease and the site 
207 in the reverse transcriptase were associated with differences in the viral load and CD4+ T-cell counts before 
adjustment for multiple comparisons (Supplementary Tables 5 and 6).
Discussion
Our results demonstrate that the sub-subtype A1 viruses circulating in Portugal had three distinct historical 
and geographic origins: related to the Eastern European outbreak; isolates from the African continent; and the 
emergent Greek-Cyprus epidemic. A similar pattern was observed by Lai A. et al.30 when characterizing the 
sub-subtype A1 epidemic in Italy. These authors concluded that sub-subtype A1 entered Italy originated from 
three geographic locations30. We found no evidence of an evolutionary relationship between the A1 sequences 
from that study30 and the sequences herein reported. Thus, the introductions of sub-subtype A1 viruses in 
Portugal and Italy are likely to be independent.
Only a minority of A1 sequences isolated in Portugal was found in migrants and clustered with sequences 
isolated from their countries of origin. These cases are likely to be infections acquired abroad and with limited 
spread in Portugal. In contrast, the Greece-Cyprus introduction resulted in a large transmission chain established 
among Portuguese natives, the MA1. The sub-subtype A1 has been increasing in prevalence in Greece47, repre-
senting 30% of the new diagnosis between 2002 and 200519. This expansion continued26,48 making sub-subtype 
A1 responsible for most of HIV-1 infections in some Greek cohorts, suggesting a possible advantage to previous 
established subtypes. The high prevalence of sub-subtype A1 in Greece may have been the preponderant factor 
for the establishment of the link between Portugal and Greece suggested by our analyses. Therefore, our results 
highlight an additional case of increasing number of infections by a non-B subtype in an European country unre-
lated with migrants from outside Europe.
The characterization of the six transmission clusters made evident that the main clade of sub-subtype A1 
infections in Portugal is related to MSM route of transmission among Portuguese. Moreover, this characterization 
revealed that there was some level of compartmentalization of the HIV-1 transmission in Portugal at a region 
level. However, TC6 encompassed sequences isolated in several countries, indicating a larger geographical spread. 
The disparity seen in TC5, composed only by males but mainly reporting heterosexual transmission route can 
be explained by the previously described MSM under-reporting49,50. Furthermore, “missing-links” can still exist, 
related to unavailable data that could help explain this disparity. Except for TC4, all the transmission clusters have 
sequences isolated from a range of years superior to six. This shows that our approach was successful in character-
izing the most recent history of these clusters. Our previous work studying HIV-1 infections from all subtypes in 
the region of Minho (Portugal) from the years 2000 to 201225 showed a statistical significant increase in the detec-
tion of A1 infections. In the present work we characterized a monophyletic clade (MA1) with six transmission 
clusters, an MRCA not older than 2000 and less than 16 years of cluster depth. Together these results demonstrate 
that the transmission history of the sub-subtype A1 in Portugal occurred mainly in the last two decades.
We believe that even if older samples were available the dating of the MRCA of the MA1 as 1996 and the 
beginning of the transmission clusters in the 2000s would not change significantly. These estimations are in 
accordance to what was previously described by Carvalho A. et al.25 about an A1 transmission chain, and the 
report by Esteves A. et al.51 of sub-subtype A1 virus circulation in Portugal in the late 90s (1997 to 2001).
The indication of Greece as the geographic location of origin for the spread of these sub-subtype A1 viruses 
in other European countries highly depends on the data available in public databases. However, our aim was to 
characterise the most recent history of these A1 sequences in Europe. We cannot exclude the possibility of miss-
ing data being brought to light showing that there were intermediate steps in the transmission not visible in our 
analyses.
Upon introduction of a HIV-1 subtype to a novel region its capacity to become established and lead to the 
formation of large transmission chains is somewhat elusive. The sub-subtype A1 was previously characterised as a 
viral genotype that could lead to a slow disease progression in different host populations7–9,52–55. Here we observed 
Figure 4. Comparison of infection progression outcomes between the MA1 study group and the control group 
(B subtype). There were statistically significant differences between the two study groups regarding CD4+ 
T-cell counts (A) and viral load (B). *At a significance level of 0.05 using the Mann-Whitney-Wilcoxon Test 
(p < 0.05).
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a statistically significant difference between the CD4+ T-cell counts, and viral load of patients followed in Portugal 
and infected by virus of the MA1 compared to subtype B. Given that the two groups were normalised for factors 
known to influence CD4+ T-cell counts and viral load, these results suggest that the infection by MA1 viruses 
may lead to a lower viral load and a slower decrease of the CD4+ T-cell count when compared with infections by 
a virus of the predominant subtype.
A total of 24 sites, 15 in protease and 19 in reverse transcriptase, showed statistically significant differences in 
the amino acid proportions between subtype groups. Of those sites, 12 were previously associated with changes 
in the viral fitness (Supplementary Tables 3 and 4). When comparing several protease mutations, M. Parera et al.42 
demonstrated that modifications in sites 14, 20, 35, 36, 37, 41, 57, 63, 64, 71 and 89 had an impact in this protein 
catalytic efficiency. The substitution M36I was also reported as having an impact in the virion maturation43. The 
protease site 63 had been associated with compensatory mutations with replication benefits44. Variations in the 
amino acid at protease position 64 were previously associated with differences in the viral replication capacity45. 
The reverse transcriptase site 207 has been associated with viral fitness alterations46. Nevertheless, in our study 
we found no statistically significant association between these sites and viral load or CD4+ T-cell counts. To our 
knowledge, the remaining 12 sites were not previously associated with impact in the viral fitness. We cannot 
conclude that changes in these sites can influence the natural history of HIV-1 infection, further studies need to 
be conducted. Moreover, sites that we did not explore, like the C2V3 sequence in HIV-1 envelope56, may have 
a strong impact in the CD4+ T-cell counts that we cannot evaluate in the present study. Nonetheless, given the 
previous reports of a slower CD4+ T-cells depletion caused by sub-subtype A1 virus7–9,52–55 a better understanding 
of the genetic characteristics of this HIV-1 sub-subtype is necessary. With our characterization, we provide the 
basis for a more focused work tackling the clinical significance of sub-subtype A1 genetic diversity and its impact 
on the European HIV-1 epidemic.
The prevalence of HIV-1 subtypes is changing21–23. We need to better understand the causes behind these 
changes, and their impact on the HIV-1 infection. In recent years sub-subtype A1 became extremely common 
in Greece26,48. Now it is increasing among new infections in Portugal, and potentially other Western European 
countries. Further HIV-1 surveillance studies are required to evaluate this phenomenon and elucidate its 
consequences.
Methods
Study Population. The inclusion criteria for this study were: (i) availability of partial HIV-1 genome 
sequence; (ii) infection with sub-subtype B or A1 virus; (iii) absence of previous antiretroviral treatment upon 
sampling. Data was collected from HIV-1 infected patients followed at Hospital de Braga from 2007 until 2017 
and from other 13 Portuguese hospital centres taking part in the BEST HOPE surveillance study from 2016 until 
2017 (Supplementary Table 7). For all cases matching the criteria the following patient secondary data was col-
lected: self-reported transmission route; gender; birth year; nationality; self-reported country of infection; date of 
the viral sample collection for sequencing; CD4+ T-cell count at sampling; viral load at sampling. The collection of 
the patient’s data was performed anonymously after approval by the ethic comities of each healthcare institution.
Sequencing. Viral RNA was extracted from plasma using MagNA Pure total nucleic acid isolation kits 
(Roche Applied Science). DNA sequencing, from the reverse transcriptase PCR amplicons was performed with 
the TrugeneTM HIV-1 genotyping system (Siemens Healthcare Diagnostics) and ViroSeqTM genotyping system 
(Abbott Molecular). The sequenced portion corresponds to the pol region, from position 2253 to 3554 (with some 
variability related to the used primers). The HIV-1 positions in this study refer to the HXB2 HIV-1 reference 
genome (GenBank: K03455.1). All multiple sequence alignments were performed using MUSCLE v3.857. The 
sequences obtained in this study were made available in GenBank (accession numbers in Supplementary Table 8) 
or are part of the BEST-HOPE program database.
Database queries. Two databases were queried: the NCBI full nucleotide collection and the HIV reference 
sequence database (http://www.hiv.lanl.gov/) using BLAST58,59. From each of 65 A1 sequences obtained in this 
study three different input queries were constructed: (i) full sequence; (ii) protease region; (iii) reverse tran-
scriptase region. Each database query generated 10 outputs. We excluded duplicates, results missing collection 
date or geographic origin, and sequences showing evidence of recombination60. Applying these criteria 425 data-
base sequences were selected for this study. Codons related to major antiretroviral drug resistance61 were excluded 
from the multiple sequence alignments prior to phylogenetic analysis.
Phylogenetic analysis. An alignment of 490 sequences was used to make a phylogenetic reconstruction 
using PhyML v3.062. The best fitting substitution model was GTR + G4 + I, determined by PhyML SMS63. Tree 
search started from 10 random trees using SPR and NNI methods. The tree with the best likelihood value was 
selected. For the in-detail study of the most recent history of the sub-subtype A1 in Portugal the main A1 clade, 
composed by 52 of the study sequences (52 of 65, 80%) and by the most closely related database sequences (total 
n = 99) was further explored by the following analysis. The maximum likelihood tree was built with the param-
eters described above. This phylogenetic representation was used to infer the correlation between genetic dis-
tance and time, using TempEst v1.564, and to characterize the transmission clusters. The same phylogeny was 
inferred for a near full-length alignment (for those sequences with available data) to compare topological altera-
tions (Supplementary Fig. 2). Bayesian evolutionary and phylogeographic analyses were performed using BEAST 
v1.865,66, with BEAGLE library v2.167. The site model used in all the BEAST analyses was GTR + G4 + I for two 
different codon partitions (1 + 2, 3). According to path and stepping-stone sampling68–70, the coalescent skygrid 
model with an uncorrelated relaxed clock showed the best fit (Supplementary Table 9). Three different runs (ran-
dom seeds), of 30 million generations, converged to similar values. Outputs were analyzed with Tracer v1.6 to 
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ensure all parameters had an effective sampling size (ESS) superior to 300. The three multiple tree output files 
were combined, using LogCombiner v1.865 and used to build the maximum clade credibility tree with mean 
heights using TreeAnnotator v1.865, excluding 10% burn-in. The skygrid plot was also created (Supplementary 
Fig. 3). In the phylogeographic analysis the sampling country was used as a discrete trait71, with a total of 12 dif-
ferent discrete locations (Fig. 3).
Definition of transmission cluster and tree visualization. The criteria for the definition of a clade 
as a transmission cluster, chosen after performing a sensitivity analysis of the relevant factors (Supplementary 
Table 10), were: likelihood ratio test (aLRT) SH-like branch support ≥0.95 (estimated with PhyML v3); branch 
posterior probability ≥0.99 (estimated with BEAST v1.8); mean cluster genetic distance <0.003 substitutions 
per site; and maximum genetic distance <0.05 substitutions per site. MEGA v7.072 was used for genetic distance 
calculation.
For the visualization and manipulation of the trees in this study the software FigTree v1.4 and the R packages 
ggtree v1.10.573 and APE v5.074 were used. The phylogeographic representation was created with SpreaD375. The 
countries locations were plotted as their geographic center.
Statistical analysis. To investigate associations between the infection with the most transmitted 
sub-subtype A1 virus clade in Portugal (identified as MA1) and the levels of CD4+ T-cells and viral load two 
groups were compared: i) cases infected with sub-subtype A1 virus from MA1 (n = 50, 11 cases were excluded 
due to lack of clinical data); ii) cases infected with the geographically most prevalent subtype (B) virus (n = 42). 
All corresponding to treatment naive individuals. The B group was created from the 170 available subtype B cases 
(Supplementary Table 11) to match the MA1 group in factors known to influence the disease progression: gender 
(p > 0.05, Fisher’s exact test), age (p > 0.05, Mann-Whitney-Wilcoxon Test), and proportion of ambiguous sites 
(PAS) (p > 0.05, Mann-Whitney-Wilcoxon Test). PAS was used to normalize the time after infection as it was 
shown to positively correlate with this variable38–41.
To study the association of amino acid variants with these two groups, their prevalence was compared using 
Fisher’s exact test, at a 0.05 significance level. To infer the association of amino acid variants with changes in the 
CD4+ T-cell counts or viral load, the sequences from the two previously mentioned groups (MA1 and B, n = 92) 
were grouped according to the amino acid variant present in each site. The groups for each variant for each 
amino acid position were compared (Mann-Whitney-Wilcoxon Test and T-test, at a 0.05 significance level, using 
Bonferroni correction for multiple comparisons). The statistical tests were performed using R v3.4.376.
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